Presymptomatic Awareness of BRCA1/BRCA2 Status and Outcomes in Women With Ovarian Cancer

被引：0
|
作者：
Armon, Shunit [1 ,2 ,3 ]
Hollander, Adi [3 ,4 ]
Segev, Yakir [5 ]
Rosengarten, Ora [2 ,3 ,6 ]
Tomer, Ariela [2 ,7 ]
Levy-Lahad, Ephrat [2 ,3 ,7 ]
Michaelson-Cohen, Rachel [1 ,2 ,3 ,7 ]
机构：
[1] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, 12 Shmuel Bait St,POB 3235, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Eisenberg R&D Author, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Hadassa Med Ctr, Dept Internal Med, Jerusalem, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Carmel Med Ctr, Dept Gynecol Oncol, Haifa, Israel
[6] Shaare Zedek Med Ctr, Helmsley Canc Ctr, Med Ctr, Jerusalem, Israel
[7] Shaare Zedek Med Ctr, Fuld Family Med Genet Inst, Jerusalem, Israel
来源：
JAMA NETWORK OPEN | 2025年 / 8卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2025.1435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] OVARIAN CANCER SCREENING BY AUSTRALIAN WOMEN FROM FAMILIES WITH BRCA1 OR BRCA2 MUTATIONS
    Wuttke, M.
    Milne, R.
    Weideman, P.
    Picken, S.
    Smith, C.
    Friedlander, M.
    McLachlan, S.
    Hopper, J. L.
    Phillips, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 223 - 224
  • [22] Evaluating Women With Ovarian Cancer for BRCA1 and BRCA2 Mutations: Missed Opportunities Reply
    Lu, Karen H.
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (02): : 441 - 441
  • [23] Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
    Xia, Yue Yin
    Gronwald, Jacek
    Karlan, Beth
    Lubinski, Jan
    McCuaig, Jeanna M.
    Brooks, Jennifer
    Moller, Pal
    Eisen, Andrea
    Sun, Sophie
    Senter, Leigha
    Bordeleau, Louise
    Neuhausen, Susan L.
    Singer, Christian F.
    Tung, Nadine
    Foulkes, William D.
    Sun, Ping
    Narod, Steven A.
    Kotsopoulos, Joanne
    GYNECOLOGIC ONCOLOGY, 2022, 164 (03) : 514 - 521
  • [24] Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
    Andrea E. Wahner Hendrickson
    Jamie N. Bakkum-Gamez
    Fergus J. Couch
    Karthik Ghosh
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 3107 - 3109
  • [25] Family History and BRCA1/BRCA2 Status Among Japanese Ovarian Cancer Patients and Occult Cancer in a BRCA1 Mutant Case
    Hirasawa, Akira
    Masuda, Kenta
    Akahane, Tomoko
    Ueki, Arisa
    Yokota, Megumi
    Tsuruta, Tomohiko
    Nomura, Hiroyuki
    Kataoka, Fumio
    Tominaga, Eiichiro
    Banno, Kouji
    Makita, Kazuya
    Susumu, Nobuyuki
    Sugano, Kokichi
    Kosaki, Kenjiro
    Kameyama, Kaori
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (01) : 49 - 56
  • [26] Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
    Hendrickson, Andrea E. Wahner
    Bakkum-Gamez, Jamie N.
    Couch, Fergus J.
    Ghosh, Karthik
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3107 - 3109
  • [27] BRCA1 and BRCA2 cancer risks
    Antoniou, Antonis C.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Evans, D. Gareth
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) : 3312 - 3313
  • [28] BRCA1 and BRCA2 in breast cancer
    Yang, XH
    Lippman, ME
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 54 (01) : 1 - 10
  • [29] Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
    Porcu, Eleonora
    Cillo, Giulia Maria
    Cipriani, Linda
    Sacilotto, Federica
    Notarangelo, Leonardo
    Damiano, Giuseppe
    Dirodi, Maria
    Roncarati, Ilaria
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (03) : 709 - 715
  • [30] BRCA1 and BRCA2 in breast cancer
    Lee, WH
    Boyer, TG
    LANCET, 2001, : S5 - S5
12345